Abstract
Synthetic cis-regulatory systems consisting of positively and negatively acting cis-regulatory modules of the Endo16 gene were combined with the lineage-specific regulatory element of the SM50 gene associated with a reporter and injected into eggs of sea urchins. We show here that synthetic cis-regulatory systems consisting of the positive Endo16 regulatory elements linked with the SM50 regulatory element are expressed spatially exactly as the sum of the individual endodermal and skeletogenic expression patterns. In combination, both lineage-specific positive regulatory elements function autonomously. However, addition of the Endo16 regulatory module that represses ectopic skeletogenic expression of Endo16 receptor constructs does not affect expression driven by the SM50 regulatory elements in the same skeletogenic cells. The repression function of this element is thus dedicated to control of the positive spatial output of the Endo16 regulatory system.
Keywords: transcriptional control, regulatory modules, Endo16, SM50
The question addressed in this paper is whether a predictable combination of embryonic spatial gene expression patterns can be generated by combining cis-regulatory elements from diverse genes. We generated chimeric cis-regulatory systems by combining spatial control elements of the sea urchin genes Endo16 and SM50. These elements individually direct expression to the endoderm and skeletogenic domains of the embryo, respectively. When physically linked in single constructs, these elements were observed to function autonomously and additively, producing a novel combined spatial pattern of expression in the embryo.
In recent studies (1, 2, 3, 4, 5), we experimentally defined the cis-regulatory systems of the SM50 and Endo16 genes of Strongylocentrotus purpuratus. These are expressed, respectively, in the skeletogenic mesenchyme lineages and in the endoderm of the embryo, in entirely nonoverlapping patterns. Endo16 encodes a secreted cell surface protein (6). The gene is transcribed in the vegetal plate of the early embryo and throughout the archenteron after invagination. Transcription is turned off in the secondary mesenchyme cells as they delaminate from the tip of the gut, and Endo16 expression then disappears from the foregut and the hindgut, so that at the end of embryogenesis only the midgut expresses the gene (3, 6). The 2.3-kb cis-regulatory system of Endo16 consists of at least six modules. Three of the Endo16 modules, G, B, and A (see Fig. 1) act positively and synergistically to promote expression in the endodermal lineages of the embryo (5). Each displays a particular temporal pattern of expression which also causes a modest ectopic expression in ectoderm lineages surrounding the vegetal plate, and in skeletogenic lineages, as well as correct expression in endodermal lineages. The repressive spatial functions executed by the other three modules, F, E, and DC, are required to confine expression to the vegetal plate and its derivatives (5). DC shuts off the gene in the skeletogenic mesenchyme, thus setting the lower boundary of expression, and modules E or F suffice to turn off Endo16 cis-regulatory activity in the tier of ectoderm cells adjacent to the endoderm, thus setting the upper boundary. The cis-regulatory system that controls SM50 gene expression is considerably simpler. This gene encodes a spicule matrix protein. It is expressed exclusively in the skeletogenic mesenchyme lineages, and is controlled by an ≈500-bp upstream sequence (Fig. 1A) that responds to a few key activators which are presumably present, or active, only in skeletogenic lineages throughout embryogenesis (2). There is no evidence for negative spatial control elements in the SM50 cis-regulatory system.
MATERIALS AND METHODS
Embryo Culture and Microinjection.
S. purpuratus embryos were cultured and injected as described (7, 8). They were collected at the appropriate stage and processed for chloramphenicol acetyltransferase (CAT) measurements or whole mount in situ hybridization.
Construction of Reporter Gene Constructs. Starting constructs.
The SM50·CAT construct (construct 1 of Fig. 1B) described in ref. 2, and the plasmids GBA–Bp·CAT and GDCBA–Bp·CAT described in ref. 5, were used as starting constructs (constructs 2 and 5 of Fig. 1B). These plasmids contain various fragments of regulatory DNA of SM50 or Endo16, a transcription initiation site, 5′-leader sequences, a CAT fusion gene, a simian virus 40 (SV40) 3′-trailer, and a poly(A) adenylation site. Bp denotes the Endo16 basal promoter (5).
Experimental constructs.
For the cloning of GBA–SM50·CAT and GDCBA–SM50·CAT (constructs 3 and 7, Fig. 1B), SM50·CAT was cut with HindIII and PstI. The GBA and GDCBA fragments were amplified with primers mod1 and mod2, using GBA–Bp·CAT and GDCBA–Bp·CAT as templates, respectively. The primer sequences, with introduced HindIII and PstI sites underlined, were as follows: mod1, 5′-GGAAAGCCTTCTTATTCTAATATCCAC-3′; and mod2, 5′-GGTCTGCAGAACAGTTTAACCCGG-3′. PCRs were carried out by using the conditions described in ref. 9, the fragments digested with HindIII and PstI, and subcloned into SM50·CAT. For cloning of DC–SM50·CAT (construct 4, Fig. 1B), the DC fragment of GDCBA–Bp was amplified in a PCR by using primers DC1 and DC2. Their sequences, with the SphI and BglII sites underlined, were as follows: DC1, 5′-CGGGCATGCGACTTCGAACTCATTT-3′; and DC2, 5′-CGGAGATCTGTATACCAATACCCGTT-3′. The PCR product was digested with SphI and BglII and inserted into SM50·CAT cut at the same sites. Similarly, the DC fragment was inserted into GBA–SM50·CAT at the SphI and BglII sites to obtain GBA–DC–SM50·CAT (line 8, Fig. 1B). To clone GBA–DC–Bp·CAT (construct 6, Fig. 1B), GBA–DC–SM50·CAT was digested with BglII, filled in, and cut with SacI, which releases the SM50 and CAT sequences, and the SmaI–SacI fragment of Bp·CAT (5) was inserted. The BglII–BamHI fragment of pMAL-p2 (New England Biolabs) was used as a nonfunctional spacer. This consists of an ≈900-bp sequence encoding the bacterial maltose-binding protein. It was inserted in antisense orientation into the BglII site of SM50·CAT to yield plasmid ↔SM50·CAT (construct 9, Fig. 1B). To create plasmid GDCBA↔SM50·CAT (line 10, Fig. 1B), the same pMAL-p2 fragment (↔) was inserted into GDCBA–SM50·CAT using the single BglII site. Restriction sites and primers used for cloning are indicated in Fig. 1B. Plasmids were linearized for microinjection with SacI.
CAT Measurements and Whole Mount in Situ Hybridization.
CAT enzyme activity was determined as reported (7), and whole mount in situ hybridizations were carried out according to the procedure described in ref. 9. Embryos were analyzed and digitized with a Roche Instruments imaging system using prores software and a Zeiss Axioskop microscope. Representative examples were printed on a Nikon CP-300 Printer.
RESULTS
The spatial expression patterns of the experimental constructs used in this work were assessed by whole mount in situ hybridization of CAT mRNA. Incorporation of injected reporter constructs in sea urchins is mosaic (8, 10, 11), and thus only a subset of the cells of each territory in which a given construct is expressed are stained in any individual embryo. In this study the percentages of experimental embryos displaying expression of transgenes was 62–82%, as summarized in Table 1. The eggs were injected following fertilization, and the embryos were assayed at the late gastrula stage.
Table 1.
Construct | Scored embryos* | Labeled/not labeled† (% expression‡) | Labeled, interpretable embryos | % gut expression§ | % PMC expression§ | % ectoderm expression§ |
---|---|---|---|---|---|---|
SM50·CAT | 608 | 418/190 (68.8) | 385 | 3.6 | 97.6 | 5.0 |
GBA-Bp·CAT¶ | 413 | 258/155 (62.5) | 248 | 94.4 | 9.7 | 9.3 |
GBA-SM50·CAT | 591 | 471/120 (79.7) | 436 | 72.2 | 92.9 | 8.7 |
DC-SM50·CAT | 206 | 146/60 (70.9) | 142 | 2.1 | 98.6 | 4.9 |
GDCBA-Bp·CAT¶ | 636 | 429/197 (67.5) | 422 | 97.4 | 2.8 | 9.8 |
GBA-DC-Bp·CAT | 163 | 126/37 (77.3) | 119 | 96.6 | 3.4 | 10.9 |
GDCBA-SM50·CAT | 839 | 692/147 (82.5) | 654 | 79.5 | 88.2 | 11.0 |
GBA-DC-SM50·CAT | 260 | 200/60 (76.9) | 191 | 89.5 | 88.5 | 12.0 |
↔SM50·CAT | 226 | 150/76 (66.4) | 141 | 2.1 | 100 | 5.7 |
GDCBA↔SM50·CAT | 272 | 211/61 (77.6) | 187 | 86.6 | 80.2 | 10.2 |
Gastrulae were collected at 48–54 h postfertilization. PMC, primary mesenchyme cell.
Values represent data from at least four separate experiments carried out on independent batches of eggs.
Embryos with more than two labeled cells were scored as labeled.
Percent expression = [Σ labeled embryos/Σ labeled + unlabeled embryos] × 100.
Percent territorial expression = [Σ embryos labeled in given territory/Σ labeled, interpretable embryos].
Exactly comparable data were obtained in ref. 5; see table 2 therein. Specifically, ectopic expression generated by GBA-Bp·CAT was 9.4% in PMCs and 15.0% in ectoderm, while in GDCBA-Bp·CAT it was 1.4% in PMCs and 2.6% in ectoderm. Essentially the same data were obtained with the complete construct—i.e., Endo16·CAT. All of these constructs were expressed in endoderm in ≥94% of stained embryos, as in the present work.
Combination of Cell-Type-Specific Modules Results in Expression in Both Territories.
G, B, and A, the positive endoderm-specific modules of the Endo16 gene (see above and Fig. 1A), were linked to the SM50 regulatory element that is necessary and sufficient to promote specific, high-level expression in skeletogenic mesenchyme (PMC) cells. At the gastrula stage when the observations were made these are the primary or skeletogenic mesenchyme cells. In an initial series of experiments we obtained the quantitative expression results expected for the GBA (5) and SM50 (2) regulatory elements when these are tested separately. The control construct SM50·CAT, shown diagrammatically in Fig. 1B, carries the entire cis-regulatory element of the SM50 gene. This construct is expressed almost exclusively in the skeletogenic mesenchyme cells in all specimens scored as stained. An example of this type of expression pattern, visualized by whole mount in situ hybridization, is shown in Fig. 2A, and data from embryos bearing SM50·CAT are given in Table 1. Ectopic gut and ectoderm expression are very low, equivalent to background observed with all injected constructs (3.6% and 5.0%, respectively; Table 1). These data are in very good accord with previous observations (1, 2). The second control plasmid, GBA–Bp·CAT (line 2 of Fig. 1B), is expressed in archenteron cells in ≈95% of all stained embryos (Table 1). However, GBA–Bp·CAT generates ≥10% ectopic expression in both the ectoderm and the skeletogenic mesenchyme as is shown in Table 1. These results are again almost the same as reported earlier (ref. 6; see Table 1). The GBA and SM50 regulatory sequences were combined in the fusion gene GBA–SM50·CAT (line 3 of Fig. 1B). Expression of this construct is detected in both skeletogenic mesenchyme and gut cells in a high percentage of all labeled embryos (93% and 72%, respectively; Table 1). Ectoderm cells are ectopically stained with the same frequency as observed in embryos expressing GBA–Bp·CAT (Table 1).
The expression pattern generated by GBA–SM50·CAT is the sum of those generated by the two individual control plasmids SM50·CAT and GBA–Bp·CAT. The percentages of embryos displaying staining specific to the skeletogenic mesenchyme, or the gut, respectively, appear slightly higher for the control constructs SM50·CAT and GBA–Bp·CAT than for GBA–SM50·CAT (between 5 and 20%; compare data in Table 1 for SM50·CAT expression in the skeletogenic cells and GBA–Bp·CAT expression in archenteron to GBA–SM50·CAT expression). This apparent difference is due solely to the requirement of normalizing to the number of total labeled embryos in a system in which incorporation of exogenous DNA is mosaic. That is, the total number of embryos seen to be labeled with the GBA–SM50·CAT construct is higher (≈80% versus 65%; Table 1) because embryos in which either gut or PMCs alone contain the exogenous DNA both display labeling, while embryos bearing either SM50·CAT or GBA–Bp·CAT display labeling only if the exogenous DNA happens to be located in skeletogenic or endoderm lineages, respectively. If the fractions of embryos in the GBA–Bp·CAT or SM50·CAT samples are normalized to the larger fraction of stained embryos recorded for GBA–SM50·CAT in Table 1, the levels of expression achieved by the latter turns out to be about the same as the normalized control construct values. It follows that there is no inhibitory effect of any of the components interacting with GBA on the SM50 regulatory system and vice versa. In fact, CAT assays show that the total amount of CAT enzyme produced in embryos expressing GBA–SM50·CAT is approximately one-third higher than the sum of CAT protein synthesized from SM50·CAT and GBA–Bp·CAT separately. This measurement is shown in Fig. 3 Left.
The experiments summarized in Table 1 show clearly that the GBA and SM50 regulatory modules function autonomously when combined in a single construct. Each causes transgene expression in the appropriate spatial domains of the embryo. Neither interference effects nor unanticipated expression patterns are observed, and except for a slight enhancement of overall activity levels, the functions of the Endo16 and SM50 regulatory elements appear strictly additive.
DC Does Not Affect Expression of SM50 Constructs in Skeletogenic Cells.
In the normal context of the Endo16 control system repression of the weak ectopic skeletogenic expression that would otherwise be caused by the positive GBA regulators is accomplished by the DC module. Yuh and Davidson (5) showed that an interaction with module A is required in order for module DC to carry out this function. Since DC precludes Endo16 expression in skeletogenic cells, we next asked whether this module would also effect the positive SM50 regulators in the same cells. This would be the case if DC generates a dominant negative interaction with components of the transcription apparatus in these cells. Thus DC was linked to SM50·CAT (DC–SM50·CAT, line 4 of Fig. 1B), and its expression was compared with that of the control SM50·CAT construct. As illustrated in Fig. 2B, spatial expression of the SM50·CAT transgene is not affected at all by addition of DC. There is no apparent decrease in PMC expression. Thus 68.8% of injected embryos express detectable SM50·CAT and 70.9% express DC–SM50·CAT (Table 1); the fraction of embryos scoring positive by whole mount in situ hybridization is a sensitive measure of the level of expression (5, 9). On the other hand, when the same batches of embryos are injected with GDCBA–Bp·CAT (line 5 of Fig. 1B) the 10% ectopic PMC expression observed with GBA–Bp·CAT is eliminated, reducing skeletogenic expression to background levels (Table 1). An example of an embryo bearing GDCBA–Bp·CAT and displaying expression exclusively in the gut is shown in Fig. 2C. These data are again in excellent quantitative agreement with previous observations (6), which for comparison are reproduced in Table 1, and they confirm that DC is a repressor of ectopic Endo16 expression in PMCs. Since DC does not affect expression of the SM50 regulators in the DC–SM50·CAT construct, while it eliminates all but background expression of GDCBA–Bp·CAT, the repressive effects of this module are apparently dedicated to the Endo16 regulatory system.
In construct DC–SM50·CAT module DC is directly upstream of the SM50 regulatory sequences. To test whether the position of DC affects its function, we constructed plasmid GBA–DC–Bp·CAT (line 6 of Fig. 1B), which more closely reflects the arrangement in DC–SM50·CAT with respect to the distance of DC to the start site compared with GDCBA–Bp·CAT. Table 1 shows that GBA–DC–Bp·CAT expression in the three embryonic territories monitored is indistinguishable from that of GDCBA–Bp·CAT. An embryo expressing GBA–DC–Bp·CAT in gut cells is illustrated in Fig. 2D.
Reporter constructs carrying a combination of GDCBA or GBA–DC plus SM50 (GDCBA–SM50·CAT and GBA–DC–SM50·CAT, lines 7 and 8 of Fig. 1B, respectively), also express the CAT fusion gene in a very high fraction of both skeletogenic mesenchyme and gut cells. Representative examples displaying labeled cells in both these territories are shown in Fig. 2 E and F. Again, the overall percentage of PMC, and of gut expression is higher in embryos expressing controls DC–SM50·CAT or GDCBA–Bp·CAT, respectively, than in embryos expressing GDCBA–SM50·CAT or GBA–DC–SM50·CAT (Table 1). However, normalized to the total of scored embryos, there is no significant quantitative difference between controls and experimental samples, as above. Furthermore, quantitative measurements of CAT expression show that the sum of CAT enzyme production from SM50·CAT plus GDCBA–Bp·CAT is about 30% less than that of GDCBA–SM50·CAT (Fig. 3 Right). In summary, the experiments described in this paragraph show that the PMC activity of the SM50 regulatory sequence is quantitatively impervious to repression by module DC, which eliminates the ectopic expression of Endo16 constructs in the same cells.
The Endo16 Regulatory System Functions in Combination with SM50 Regulators When Separated from Them by a Spacer.
A 900-bp spacer element was introduced between the GDCBA and the SM50 sequences of GDCBA–SM50·CAT. This construct, GDCBA↔SM50·CAT, is shown in Fig. 1B, line 10. The fragment used as a spacer was a pMAL-p2 element containing sequences of the bacterial maltose-binding protein. We first demonstrated that the spacer is not in itself functional—i.e., that it does not affect PMC expression when linked to SM50·CAT (construct ↔SM50·CAT of Fig. 1B, line 9). Results are illustrated in Fig. 2G and summarized in Table 1 (compare with SM50·CAT of Table 1). Table 1 shows that GDCBA↔SM50·CAT is expressed exactly as is GDCBA–SM50·CAT. More than 86% of all embryos scored show gut expression, and around 80% display PMC staining, as compared with 80% gut, and 88% PMC labeling in embryos injected with GDCBA–SM50·CAT (Table 1). Fig. 2H displays an embryo expressing GDCBA↔SM50·CAT in gut and PMC cells. This experiment confirms the autonomous function of the Endo16 regulatory system, and shows that its independent interaction with the basal transcription apparatus occurs efficiently over a considerable distance.
DISCUSSION
It seems remarkable that a novel gene regulatory system can be constructed simply by physically linking cis-regulatory elements from genes that function in different spatial domains. An earlier example was described by Levine and colleagues (12), who produced a synthetic cis-regulatory system by combining the modular stripe 2 element of the Drosophila evenskipped pair rule gene with an element from the gene rhomboid that produces bilateral stripes, generating a bilateral crossed pattern of expression. Here we describe the expression of a synthetic sea urchin embryo cis-regulatory system that was created by combining pieces of the Endo16 and SM50 cis-regulatory systems, and that faithfully functions in both the gut and the skeletogenic mesenchyme. In these constructs the basal promoter utilized is that of the SM50 gene, which happens to have a TATA-less initiator. However, Makabe et al. (2) showed that the SM50 cis-regulatory system functions just as well when the initiator sequence is replaced by a synthetic TATA box sequence. Active expression driven by the Endo16 regulators when they are linked to SM50·CAT requires that the positive upstream modules of Endo16, G, B, and A, interact just as efficiently with the SM50 basal transcription apparatus as with its own TATA box-containing promoter. This is shown by the results of Fig. 3, which demonstrate that the linked construct GBA–SM50·CAT has even more activity than the sum of the activities of Endo16–Bp·CAT (which contains the endogenous Endo16 basal promoter, Bp), plus SM50·CAT. In spatial terms the combined construct expresses exactly as does the sum of the individual expression domains imposed by the separate SM50 and Endo16 regulatory systems. Furthermore, the Endo16 cis-regulatory modules interact efficiently with the basal SM50 promoter when placed about a kilobase further away. Earlier studies on both the SM50 (2) and the Endo16 (5) regulatory systems showed that both also function when associated with SV40 basal promoters. The implication of these studies together with the present demonstration is clearly that the basal promoter apparatus is promiscuous; all the specificity for developmental function lies in the distal cis-regulatory systems, and each of those tested here has an autonomous capability of animating the basal promoter apparatus. This is the reason that it is possible to create synthetic spatial regulatory systems by combining upstream regulatory elements from different genes. To our knowledge, this is the first observation of this kind for a type 1 embryonic system (13), as the previous examples are confined to Drosophila (12).
The experiments utilizing the negative DC regulatory module of Endo16 show that it does not affect expression driven by the SM50 regulators in skeletogenic cells, though in these same cells it reduces expression driven by the GBA regulators of Endo16 to background levels. DC is therefore not a dominant silencer of transcription in these cells. With respect to the Endo16 and SM50 regulatory systems it is likely that DC is dedicated to Endo16. This observation confirms and extends the previous finding that the function of DC requires interaction with module A of Endo16 (5). However, we cannot rigorously exclude the possibility that DC fails to affect expression driven by the SM50 regulators because of some particular characteristic of the SM50 basal promoter, or because the DC repressor may bind too far away from the SM50 activators, although we note that no repressive effect was observed when DC module was brought into direct apposition in the construct DC–SM50·CAT.
Repressive elements that control spatial expression by dedicated interaction with particular positive regulatory elements within the cis-regulatory system may be a very general and essential feature of developmental gene regulation. To consider only some particularly well studied examples from embryonic spatial gene control systems, such locally acting negative regulators are known for Drosophila, in the eve stripe 2 (14, 15), and stripe 3 (16) modules; in the rhomboid lateral stripe element (17); and in the Kruppel embryonic expression element (18); and for the sea urchin, in the middle module of the CyIIIa cytoskeletal actin gene (9, 19) as well as in the Endo16 gene (5). These are all examples of local dedicated interaction of negative regulatory elements with other elements that function positively, such that if they were not repressed in given embryonic territories, ectopic spatial expression would result. This is an important and general feature of the modular autonomy of cis-regulatory systems. It contributes to the flexibility with which spatial control elements can be combined in novel arrangements without abrogating function. That is, a high complexity of positive–negative interactions is afforded by the diverse arrays of upstream transcription factors, compared with a system in which expression is mediated only by direct interaction of the various repressors with the same basal transcription apparatus. In any case, in the example studied here, the DC skeletogenic repressor of Endo16 has no dominant silencing activity in the cells in which it is active.
Of course the main implication of the experimental assembly of a synthetic regulatory system is that it emphasizes the likelihood that cis-regulatory recombination has been a major evolutionary mechanism for the generation of new developmental regulatory systems. This is scarcely a new idea (20). But it is only recently that it has become possible to demonstrate experimentally the remarkable lack of constraint in the identity of compatible elements, in spacing, in functionality, or in linear arrangement, that is a major characteristic of modular cis-regulatory organization.
Acknowledgments
We thank Dr. Steve Small of New York University and Drs. Ellen Rothenberg and James A. Coffman of the California Institute of Technology for reviewing this manuscript. This work was supported by National Institutes of Health Grant HD-05753 to E.H.D. and a Gosney Fellowship to L.D.B.
Footnotes
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Abbreviations: CAT, chloramphenicol acetyltransferase; PMC, primary mesenchyme cell.
References
- 1.Sucov H M, Hough-Evans B R, Franks R R, Britten R J, Davidson E H. Genes Dev. 1988;2:1238–1250. doi: 10.1101/gad.2.10.1238. [DOI] [PubMed] [Google Scholar]
- 2.Makabe K W, Kirchhamer C V, Britten R J, Davidson E H. Development (Cambridge, UK) 1995;121:1957–1970. doi: 10.1242/dev.121.7.1957. [DOI] [PubMed] [Google Scholar]
- 3.Ransick A, Ernst S G, Britten R J, Davidson E H. Mech Dev. 1993;42:117–124. doi: 10.1016/0925-4773(93)90001-e. [DOI] [PubMed] [Google Scholar]
- 4.Yuh C-H, Ransick A, Martinez P, Britten R J, Davidson E H. Mech Dev. 1994;47:165–186. doi: 10.1016/0925-4773(94)90088-4. [DOI] [PubMed] [Google Scholar]
- 5.Yuh C-H, Davidson E H. Development (Cambridge, UK) 1996;122:1069–1982. doi: 10.1242/dev.122.4.1069. [DOI] [PubMed] [Google Scholar]
- 6.Nocente-McGrath C, Brenner C A, Ernst S G. Dev Biol. 1991;136:264–272. doi: 10.1016/0012-1606(89)90147-4. [DOI] [PubMed] [Google Scholar]
- 7.McMahon A P, Flytzanis C N, Hough-Evans B R, Katula K S, Britten R J, Davidson E H. Dev Biol. 1985;108:420–430. doi: 10.1016/0012-1606(85)90045-4. [DOI] [PubMed] [Google Scholar]
- 8.McMahon A P, Novak T J, Britten R J, Davidson E H. Proc Natl Acad Sci USA. 1985;81:7490–7494. doi: 10.1073/pnas.81.23.7490. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Kirchhamer C V, Davidson E H. Development (Cambridge, UK) 1996;122:333–348. doi: 10.1242/dev.122.1.333. [DOI] [PubMed] [Google Scholar]
- 10.Hough-Evans B R, Franks R R, Cameron R A, Britten R J, Davidson E H. Dev Biol. 1987;121:576–579. doi: 10.1016/0012-1606(87)90193-x. [DOI] [PubMed] [Google Scholar]
- 11.Franks R R, Anderson R, Moore J G, Hough-Evans B R, Britten R J, Davidson E H. Development (Cambridge, UK) 1990;110:31–40. doi: 10.1242/dev.110.1.31. [DOI] [PubMed] [Google Scholar]
- 12.Cai H N, Arnosti D N, Levine M. Proc Natl Acad Sci USA. 1996;93:9309–9314. doi: 10.1073/pnas.93.18.9309. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Davidson E H. Development (Cambridge, UK) 1991;113:1–26. doi: 10.1242/dev.113.1.1. [DOI] [PubMed] [Google Scholar]
- 14.Small S, Blair A, Levine M. EMBO J. 1992;11:4047– 4057. doi: 10.1002/j.1460-2075.1992.tb05498.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Small S, Blair A, Levine M. Dev Biol. 1996;175:314– 324. doi: 10.1006/dbio.1996.0117. [DOI] [PubMed] [Google Scholar]
- 16.Arnosti D N, Barolo N, Levine M, Small S. Development (Cambridge, UK) 1996;122:205–214. doi: 10.1242/dev.122.1.205. [DOI] [PubMed] [Google Scholar]
- 17.Ip Y T, Park R E, Kosman D, Bia E, Levine M. Genes Dev. 1992;6:1728–1729. doi: 10.1101/gad.6.9.1728. [DOI] [PubMed] [Google Scholar]
- 18.Hoch M, Gerwin H, Taubert H, Jäckle H. Science. 1992;256:94–97. doi: 10.1126/science.1348871. [DOI] [PubMed] [Google Scholar]
- 19.Coffman J A, Kirchhamer C V, Harrington M G, Davidson E H. Dev Biol. 1996;174:43–54. doi: 10.1006/dbio.1996.0050. [DOI] [PubMed] [Google Scholar]
- 20.Britten R J, Davidson E H. Q Rev Biol. 1971;46:111–138. doi: 10.1086/406830. [DOI] [PubMed] [Google Scholar]